About Us

Established in Shenzhen in 2004 as a wholly-owned subsidiary of Shenzhen Hepalink Pharmaceutical Co., Ltd., Techdow Pharmaceutical is a leading Chinese exporter of enoxaparin sodium APIs and low molecular weight heparin (LMWH) formulations

Techdow’s enoxaparin sodium injection is the first enoxaparin sodium biosimilar approved by the European Medicines Agency (EMA) and the company’s products are currently being sold to over 40 countries and regions, winning recognition and praise from its customers.

Our Strength

Techdow has a comprehensive quality control system that is stringently enforced to ensure the stability and controllability of the manufacturing process. Our production lines are compliant with the highest GMP standards adopted by some of the major markets worldwide, enabling us to provide patients with safe and effective medicines and services for the protection of their health.

  • Stringent Quality Control

  • Ample Production Capacity

  • Reliable Supplies

  • A Global Distribution Network

Join Us

We invite you to join and grow with Techdow's diverse and globalized team. We see talents as the cornerstone of our vitality and sustained growth. We believe the success of personal growth and success can only be possible when we excel as a team.

Legal statement

Copyright ©2022 Shenzhen Techdow Pharmaceutical Co., Ltd